Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector

Biomaterials

Volumn 29, Issue 9, 2008, Pages 1242-1249

  Vogt, Stephan ^a   Ueblacker, Peter ^b   Geis, Christopher ^a   Wagner, Bettina ^a   Wexel, Gabriele ^a   Tischer, Thomas ^a   Krüger, Achim ^a   Plank, Christian ^a   Anton, Martina ^a   Martinek, Vladimir ^a   Imhoff, Andreas B ^a   Gansbacher, Bernd ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ATDC5; Chondrocytes; Gene transfer; Retroviral vector; Transduction

Indexed keywords

ENZYME ACTIVITY; GENE TRANSFER; GROWTH RATE; LIVING SYSTEMS STUDIES;

CHONDROCYTES; RETROVIRAL VECTOR;

CELLS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 NITROPHENYL PHOSPHATE; ALCIAN BLUE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; DYE; GROWTH FACTOR; PROTEOGLYCAN; RETROVIRUS VECTOR;

ANIMAL CELL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL PROLIFERATION; CHEMICAL REACTION; CHONDROGENESIS; CONTROLLED STUDY; EGFP GENE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; REPORTER GENE; STAINING; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LAC OPERON; MICE; PROTEOGLYCANS; RABBITS; RECOMBINANT PROTEINS; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ORYCTOLAGUS CUNICULUS;

EID: 38349019674     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.11.013     Document Type: Article

References (42)

1. Knutsen G., Drogset J.O., Engebretsen L., Grontvedt T., Isaksen V., Ludvigsen T.C., et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 89 (2007) 2105-2112
2. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., and Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331 (1994) 889-895
3. Huard J., Li Y., Peng H., and Fu F.H. Gene therapy and tissue engineering for sports medicine. J Gene Med 5 (2003) 93-108
4. Ueblacker P., Wagner B., Vogt S., Salzmann G., Wexel G., Kruger A., et al. In vivo analysis of retroviral gene transfer to chondrocytes within collagen scaffolds for the treatment of osteochondral defects. Biomaterials 28 (2007) 4480-4487
5. Chou C.H., Cheng W.T., Kuo T.F., Sun J.S., Lin F.H., and Tsai J.C. Fibrin glue mixed with gelatin/hyaluronic acid/chondroitin-6-sulfate tri-copolymer for articular cartilage tissue engineering: the results of real-time polymerase chain reaction. J Biomed Mater Res A 82 (2007) 757-767
6. Shao X.X., Hutmacher D.W., Ho S.T., Goh J.C., and Lee E.H. Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits. Biomaterials 27 (2006) 1071-1080
7. Trippel S.B. Growth factors as therapeutic agents. Instr Course Lect 46 (1997) 473-476
8. Bobacz K., Gruber R., Soleiman A., Graninger W.B., Luyten F.P., and Erlacher L. Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. Osteoarthr Cartil 10 (2002) 394-401
9. Rosier R.N., and O'Keefe R.J. Autocrine regulation of articular cartilage. Instr Course Lect 47 (1998) 469-475
10. Sah R.L., Chen A.C., Grodzinsky A.J., and Trippel S.B. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. Arch Biochem Biophys 308 (1994) 137-147
11. Sato K., and Urist M.R. Bone morphogenetic protein-induced cartilage development in tissue culture. Clin Orthop Relat Res 183 (1984) 180-187
12. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534
13. Evans C.H., and Robbins P.D. Possible orthopaedic applications of gene therapy. J Bone Joint Surg Am 77 (1995) 1103-1114
14. Carlberg A.L., Pucci B., Rallapalli R., Tuan R.S., and Hall D.J. Efficient chondrogenic differentiation of mesenchymal cells in micromass culture by retroviral gene transfer of BMP-2. Differentiation 67 (2001) 128-138
15. Gooch K.J., Blunk T., Courter D.L., Sieminski A.L., Vunjak-Novakovic G., and Freed L.E. Bone morphogenetic proteins-2, -12, and -13 modulate in vitro development of engineered cartilage. Tissue Eng 8 (2002) 591-601
16. Musgrave D.S., Bosch P., Lee J.Y., Pelinkovic D., Ghivizzani S.C., Whalen J., et al. Ex vivo gene therapy to produce bone using different cell types. Clin Orthop Relat Res 378 (2000) 290-305
17. Sellers R.S., Zhang R., Glasson S.S., Kim H.D., Peluso D., D'Augusta D.A., et al. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am 82 (2000) 151-160
18. Van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., and van den Berg W.B. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthr Cartil 6 (1998) 306-317
19. Gelse K., von der Mark K., Aigner T., Park J., and Schneider H. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum 48 (2003) 430-441
20. Madry H., and Trippel S.B. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther 7 (2000) 286-291
21. Martinek V., Ueblacker P., and Imhoff A.B. Current concepts of gene therapy and cartilage repair. J Bone Joint Surg Br 85 (2003) 782-788
22. Goodrich L.R., Hidaka C., Robbins P.D., Evans C.H., and Nixon A.J. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 89 (2007) 672-685
23. Pagnotto M.R., Wang Z., Karpie J.C., Ferretti M., Xiao X., and Chu C.R. Adeno-associated viral gene transfer of transforming growth factor-beta1 to human mesenchymal stem cells improves cartilage repair. Gene Ther 14 (2007) 804-813
24. Nishikawa M., and Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12 (2001) 861-870
25. Baragi V.M., Renkiewicz R.R., Qiu L., Brammer D., Riley J.M., Sigler R.E., et al. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthr Cartil 5 (1997) 275-282
26. Ikeda T., Kubo T., Nakanishi T., Arai Y., Kobayashi K., Mazda O., et al. Ex vivo gene delivery using an adenovirus vector in treatment for cartilage defects. J Rheumatol 27 (2000) 990-996
27. Madry H., Cucchiarini M., Terwilliger E.F., and Trippel S.B. Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum Gene Ther 14 (2003) 393-402
28. Gouze E., Pawliuk R., Pilapil C., Gouze J.N., Fleet C., Palmer G.D., et al. In vivo gene delivery to synovium by lentiviral vectors. Mol Ther 5 (2002) 397-404
29. Hirschmann F., Verhoeyen E., Wirth D., Bauwens S., Hauser H., and Rudert M. Vital marking of articular chondrocytes by retroviral infection using green fluorescence protein. Osteoarthr Cartil 10 (2002) 109-118
30. Akiyama H., Fukumoto A., Shigeno C., Ito H., Mukai S., Hoshino T., et al. TAK-778, a novel synthetic 3-benzothiepin derivative, promotes chondrogenesis in vitro and in vivo. Biochem Biophys Res Commun 261 (1999) 131-138
31. Shukunami C., Shigeno C., Atsumi T., Ishizeki K., Suzuki F., and Hiraki Y. Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J Cell Biol 133 (1996) 457-468
32. Schaft N., Willemsen R.A., de Vries J., Lankiewicz B., Essers B.W., Gratama J.W., et al. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes. J Immunol 170 (2003) 2186-2194
33. Anton M., Wagner B., Haubner R., Bodenstein C., Essien B.E., Bonisch H., et al. Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells. J Gene Med 6 (2004) 119-126
34. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 9 (2002) 102-109
35. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38 (2006) 1424-1429
36. Hannallah D., Peterson B., Lieberman J.R., Fu F.H., and Huard J. Gene therapy in orthopaedic surgery. Instr Course Lect 52 (2003) 753-768
37. Ueblacker P., Wagner B., Kruger A., Vogt S., DeSantis G., Kennerknecht E., et al. Inducible nonviral gene expression in the treatment of osteochondral defects. Osteoarthr Cartil 12 (2004) 711-719
38. De Luca F., Barnes K.M., Uyeda J.A., De-Levi S., Abad V., Palese T., et al. Regulation of growth plate chondrogenesis by bone morphogenetic protein-2. Endocrinology 142 (2001) 430-436
39. Wong G.A., Tang V., El-Sabeawy F., and Weiss R.H. BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1. Am J Physiol Endocrinol Metab 284 (2003) E972-E979
40. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302 (2003) 415-419
41. Logan A.C., Haas D.L., Kafri T., and Kohn D.B. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J Virol 78 (2004) 8421-8436
42. Pluta K., Luce M.J., Bao L., Agha-Mohammadi S., and Reiser J. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J Gene Med 7 (2005) 803-817